← Back to Search

Behavioural Intervention

Asthma Intervention Programs for Asthma (PR-AIR Trial)

N/A
Waitlist Available
Led By Glorisa Canino, PhD
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children between the ages of 2 and 12 years old
Children must meet the screening criteria as having not well controlled or poorly controlled asthma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up asthma control will be measured at baseline, end of treatment (eot; 1 - 2 months after baseline, depending on intervention assignment), and every 3 months for 1 year.
Awards & highlights

PR-AIR Trial Summary

This trial aims to reduce asthma disparities in San Juan, PR, with an evidence-based multi-level intervention that promotes population health.

Who is the study for?
This trial is for children aged 2-12 with not well controlled or poorly controlled asthma, living in specific areas of San Juan, Puerto Rico. It's not suitable for kids with complex medical conditions.Check my eligibility
What is being tested?
The PR-AIR program aims to reduce asthma disparities in high-burden communities through two approaches: a low-intensity virtual package (CASE-V and HARP-V) and a high-intensity in-person package (CASE and HARP).See study design
What are the potential side effects?
Since this trial focuses on non-medical interventions to manage asthma, traditional medication side effects are not the main concern. However, there may be indirect effects related to changes in management routines.

PR-AIR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 2 and 12 years old.
Select...
My child's asthma is not well controlled.

PR-AIR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~asthma-related qol will be measured at baseline, end of treatment (eot; 1 - 2 months after baseline, depending on intervention assignment), and every three months for 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and asthma-related qol will be measured at baseline, end of treatment (eot; 1 - 2 months after baseline, depending on intervention assignment), and every three months for 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Child Asthma Control (Individual Level, ages 2-4 years)
Change in Child Asthma Control (Individual Level, ages 5-11 years)
Change in Child Asthma Control (Individual Level; ages 12 and up)
+3 more
Secondary outcome measures
Asthma-related Quality of Life (QoL) (Individual Level)
School Absences (Community Level)

PR-AIR Trial Design

2Treatment groups
Active Control
Group I: High Intensity (in-Person) Intervention ImplementationActive Control2 Interventions
During high intensity implementation, all interventions are administered in person. Specifically, families of children with poorly controlled asthma will receive in-person versions of HARP and CASE. Children with not well controlled asthma will receive an in-person version of CASE only.
Group II: Low-Intensity (Virtual) Intervention ImplementationActive Control2 Interventions
During low intensity implementation, families of children with poorly controlled asthma will be referred to the remote version of HARP (HARP-V) and will receive CASE remotely (CASE-V). Children with not well controlled asthma will receive only CASE-V remotely.

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
260 Previous Clinical Trials
71,254 Total Patients Enrolled
10 Trials studying Asthma
3,134 Patients Enrolled for Asthma
University of Puerto RicoOTHER
62 Previous Clinical Trials
20,350 Total Patients Enrolled
2 Trials studying Asthma
836 Patients Enrolled for Asthma
Glorisa Canino, PhDPrincipal InvestigatorUniversity of Puerto Rico
5 Previous Clinical Trials
1,174 Total Patients Enrolled
2 Trials studying Asthma
836 Patients Enrolled for Asthma

Media Library

CASE and HARP in person (High Intensity package) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05999032 — N/A
Asthma Research Study Groups: High Intensity (in-Person) Intervention Implementation, Low-Intensity (Virtual) Intervention Implementation
Asthma Clinical Trial 2023: CASE and HARP in person (High Intensity package) Highlights & Side Effects. Trial Name: NCT05999032 — N/A
CASE and HARP in person (High Intensity package) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05999032 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial enrollment include any adults under 25 years of age?

"Eligibility for this trial is contingent upon a patient's age; they must be between 2 and 12 years old."

Answered by AI

Is this research endeavor still recruiting participants?

"Per data available on clinicaltrials.gov, this experiment is not presently enrolling participants. It was first listed on September 1st 2023 and received its last update nearly a month ago on August 11th 2023. Although the study has concluded recruitment, there are 337 other trials recruiting patients at present time."

Answered by AI

Am I eligible to participate in this clinical trial?

"This research project is searching for a total of 480 individuals with asthma ranging from 2 to 12 years old."

Answered by AI
~320 spots leftby Jul 2026